authors
- Hendrix, Nathaniel
- Ollendorf, Daniel A
- Chapman, Richard H
- Loos, Anne
- Liu, Shanshan
- Kumar, Varun
- Jeffrey A. Linder, MD, MPH, FACP
- Pearson, Steven D
- Veenstra, David L
Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 2018
published in
has subject area
- Cost-Benefit Analysis
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Dermatologic Agents
- Drug Costs
- Humans
- Interleukin-12
- Interleukin-17
- Interleukin-23
- Markov Chains
- Middle Aged
- Models, Economic
- Molecular Targeted Therapy
- Phosphodiesterase 4 Inhibitors
- Psoriasis
- Quality-Adjusted Life Years
- Treatment Outcome
- Tumor Necrosis Factor-alpha